Literature DB >> 30518720

Involvement of Apelin/APJ Axis in Thrombogenesis in Valve Heart Disease Patients with Atrial Fibrillation.

Hai Cheng1,2, Yuhan Chen1, Xueling Li1, Fu Chen1, Jinxuan Zhao1, Jiaxin Hu1, Anqi Shan1, Shuaihua Qiao1, Zilun Wei1, Guixin He3, Biao Xu1.   

Abstract

The mechanism underlying thrombosis in atrial fibrillation (AF) is not yet clearly understood. The apelin/APJ axis parallel and counter-regulate with the angiotensin system. The present study hypothesizes that apelin/APJ axis exert its anti-thrombus effect in normal left atrial tissue and is disrupted by up-regulated renin-angiotensin-aldosterone system (RAAS) signaling during AF. The specimens of left atrial appendages collected from patients with rheumatic mitral stenosis who underwent valve replacement were divided into 3 groups: sinus rhythm, AF+/thrombus-, and AF+/thrombus+. The amounts of angiotensin II receptor subtype 1 (AT1), apelin/APJ and its downstream plasminogen activator inhibitor-1 (PAI-1) were detected by western blot. The expression of apelin/APJ was significantly decreased in the AF+/thrombus+ group compared with the sinus rhythm and AF+/thrombus- groups. Meanwhile the expressions of AT1 and PAI-1 were highest in the AF+/thrombus+ group compared to the other two groups. Taken together, the present study reveals apelin/APJ axis might be correlated with thrombosis in patients with AF mediated by PAI-1.

Entities:  

Keywords:  Angiotensin system; PAI-1; RAAS; Valve replacement

Mesh:

Substances:

Year:  2018        PMID: 30518720     DOI: 10.1536/ihj.18-166

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  2 in total

1.  Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation.

Authors:  Qiaoqiao Li; Yingyu Lai; Xiaoyan Gao; Xin Li; Chun-Yu Deng; Huiming Guo; Junfei Zhao; Hui Yang; Yuwen Xu; Shulin Wu; Yumei Xue; Fang Rao
Journal:  PeerJ       Date:  2021-06-02       Impact factor: 2.984

Review 2.  The therapeutic potential of apelin in kidney disease.

Authors:  Fiona A Chapman; Duuamene Nyimanu; Janet J Maguire; Anthony P Davenport; David E Newby; Neeraj Dhaun
Journal:  Nat Rev Nephrol       Date:  2021-08-13       Impact factor: 28.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.